Physician profile
David C Laverty
NPI 1912062753
$17,459.20
in general payments reported to CMS, 2019-2025
25 companies · $2,334 in 2025
The $2,334 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,422 · 2020: $323 · 2021: $2,541 · 2022: $4,812 · 2023: $1,825 · 2024: $2,203 · 2025: $2,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,567 · Consulting Fee: $1,500 · Travel and Lodging: $1,264 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,566.81 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,264.34 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteocentric Technologies, INC. | $7,016.83 | 2019-2025 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Sanara Medtech INC. | $3,412.91 | 2022-2025 | Biasurge, Celleraterx, Celleraterx |
| Stryker Corporation | $1,523.19 | 2019-2025 | Variax, Hoffmann, Gamma |
| Arthrex, INC. | $1,218.20 | 2024-2025 | Arthrex |
| Core Surgical Group | $681.36 | 2023-2025 | |
| Depuy Synthes Sales INC. | $643.49 | 2019-2025 | Na, Matrixrib |
| Skeletal Dynamics INC | $408.46 | 2019-2024 | Implate, Align, Ijs |
| Bone Support INC. | $341.56 | 2024 | Cerament G, Ceramentbone Void Filler |
| Medinc of Texas | $232.29 | 2022-2023 | |
| Depuy Synthes Products, INC. | $231.95 | 2022 | |
| Globus Medical, INC. | $228.19 | 2023 | Proximal Tibia Plate, Distal Femur Plate System |
| Si-Bone, INC. | $213.56 | 2020-2025 | |
| Ossur Americas, INC. | $209.86 | 2025 | |
| Smith+Nephew, INC. | $186.55 | 2023-2024 | Evos |
| Aroa Biosurgery Incorporated | $179.85 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $148.67 | 2022-2023 | |
| Illuminoss Medical, INC. | $137.91 | 2022 | |
| Acuity Surgical Devices, LLC | $128.93 | 2025 | |
| Acera Surgical, INC. | $94.00 | 2024-2025 | Restrata Wound Matrix |
| Biocomposites INC | $88.91 | 2024 | |
| Medtronic, INC. | $81.18 | 2023 | Ligasure |
| Bioventus LLC | $25.98 | 2023 | Exogen Ultrasound Bone Healing System |
| Alexion Pharmaceuticals, INC. | $14.02 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $11.35 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$156,396.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Laverty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.